Ultima Genomics is focused on driving the scale of genomic information to enable unprecedented advances in biology and improvements in human health. The company’s new sequencing architecture lowers the costs of sequencing to help overcome the tradeoffs that scientists and clinicians are forced to make between the breadth, depth, and frequency with which they use genomic information. Ultima’s new sequencing architecture is designed to scale far beyond conventional sequencing technologies, lower the cost of genomic information, and catalyze the next phase of genomics in the 21st century.